BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31628293)

  • 1. Association of decreased levels of lipopolysaccharide-binding protein with OKN-007-induced regression of tumor growth in an F98 rat glioma model.
    Smith N; Saunders D; Jensen RL; Towner RA
    J Neurosurg; 2019 Oct; 133(6):1695-1703. PubMed ID: 31628293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007.
    Towner RA; Gillespie DL; Schwager A; Saunders DG; Smith N; Njoku CE; Krysiak RS; Larabee C; Iqbal H; Floyd RA; Bourne DW; Abdullah O; Hsu EW; Jensen RL
    Neuro Oncol; 2013 Mar; 15(3):330-40. PubMed ID: 23328810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OKN-007 decreases free radical levels in a preclinical F98 rat glioma model.
    Coutinho de Souza P; Smith N; Atolagbe O; Ziegler J; Njoku C; Lerner M; Ehrenshaft M; Mason RP; Meek B; Plafker SM; Saunders D; Mamedova N; Towner RA
    Free Radic Biol Med; 2015 Oct; 87():157-68. PubMed ID: 26119786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OKN-007 decreases tumor necrosis and tumor cell proliferation and increases apoptosis in a preclinical F98 rat glioma model.
    de Souza PC; Balasubramanian K; Njoku C; Smith N; Gillespie DL; Schwager A; Abdullah O; Ritchey JW; Fung KM; Saunders D; Jensen RL; Towner RA
    J Magn Reson Imaging; 2015 Dec; 42(6):1582-91. PubMed ID: 25920494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OKN-007 Alters Protein Expression Profiles in High-Grade Gliomas: Mass Spectral Analysis of Blood Sera.
    Towner RA; Hocker J; Smith N; Saunders D; Battiste J; Hanas J
    Brain Sci; 2022 Jan; 12(1):. PubMed ID: 35053843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth.
    Towner RA; Smith N; Saunders D; Brown CA; Cai X; Ziegler J; Mallory S; Dozmorov MG; Coutinho De Souza P; Wiley G; Kim K; Kang S; Kong DS; Kim YT; Fung KM; Wren JD; Battiste J
    Transl Oncol; 2019 Feb; 12(2):320-335. PubMed ID: 30468988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ELTD1, a potential new biomarker for gliomas.
    Towner RA; Jensen RL; Colman H; Vaillant B; Smith N; Casteel R; Saunders D; Gillespie DL; Silasi-Mansat R; Lupu F; Giles CB; Wren JD
    Neurosurgery; 2013 Jan; 72(1):77-90; discussion 91. PubMed ID: 23096411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OKlahoma Nitrone-007: novel treatment for diffuse intrinsic pontine glioma.
    Thomas L; Smith N; Saunders D; Zalles M; Gulej R; Lerner M; Fung KM; Carcaboso AM; Towner RA
    J Transl Med; 2020 Nov; 18(1):424. PubMed ID: 33168005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualization of the protective ability of a free radical trapping compound against rat C6 and F98 gliomas with diffusion tensor fiber tractography.
    Asanuma T; Doblas S; Tesiram YA; Saunders D; Cranford R; Yasui H; Inanami O; Smith N; Floyd RA; Kotake Y; Towner RA
    J Magn Reson Imaging; 2008 Sep; 28(3):574-87. PubMed ID: 18777527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
    Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
    Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OKN-007 decreases VEGFR-2 levels in a preclinical GL261 mouse glioma model.
    de Souza PC; Smith N; Pody R; He T; Njoku C; Silasi-Mansat R; Lupu F; Meek B; Chen H; Dong Y; Saunders D; Orock A; Hodges E; Colijn S; Mamedova N; Towner RA
    Am J Nucl Med Mol Imaging; 2015; 5(4):363-78. PubMed ID: 26269774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting nitric oxide and NMDA receptor-associated pathways in treatment of high grade glial tumors. Hypotheses for nitro-memantine and nitrones.
    Altinoz MA; Elmaci İ
    Nitric Oxide; 2018 Sep; 79():68-83. PubMed ID: 29030124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors.
    Barth RF; Grecula JC; Yang W; Rotaru JH; Nawrocky M; Gupta N; Albertson BJ; Ferketich AK; Moeschberger ML; Coderre JA; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):267-77. PubMed ID: 14697448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates.
    Wu G; Barth RF; Yang W; Kawabata S; Zhang L; Green-Church K
    Mol Cancer Ther; 2006 Jan; 5(1):52-9. PubMed ID: 16432162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4.
    Yang W; Barth RF; Wu G; Ciesielski MJ; Fenstermaker RA; Moffat BA; Ross BD; Wikstrand CJ
    Clin Cancer Res; 2005 Jan; 11(1):341-50. PubMed ID: 15671565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model.
    Ciesielski MJ; Kazim AL; Barth RF; Fenstermaker RA
    Cancer Immunol Immunother; 2005 Feb; 54(2):107-19. PubMed ID: 15340764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rat brain tumor models to assess the efficacy of boron neutron capture therapy: a critical evaluation.
    Barth RF; Yang W; Coderre JA
    J Neurooncol; 2003; 62(1-2):61-74. PubMed ID: 12749703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using [¹⁸F]FBAU for imaging brain tumor progression in an F98/tk-luc glioma-bearing rat model.
    Chien YC; Chen JC; Lin WC; Ding HJ; Wang HE; Kao CH; Hwang JJ
    Oncol Rep; 2014 Aug; 32(2):691-9. PubMed ID: 24926696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental validation of 5 in-silico predicted glioma biomarkers.
    Towner RA; Jensen RL; Vaillant B; Colman H; Saunders D; Giles CB; Wren JD
    Neuro Oncol; 2013 Dec; 15(12):1625-34. PubMed ID: 24158112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a human glioblastoma stemlike brainstem rodent tumor model.
    Siu IM; Tyler BM; Chen JX; Eberhart CG; Thomale UW; Olivi A; Jallo GI; Riggins GJ; Gallia GL
    J Neurosurg Pediatr; 2010 Jul; 6(1):92-7. PubMed ID: 20593994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.